Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 234 across all filing types
Latest filing 2026-01-13 AGM Information
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
News release - English.pdf
AGM Information Classification · 1% confidence The document is a formal notice from a transfer agent (Endeavor Trust) to regulators regarding an upcoming Annual General Meeting (AGM) for Precore Gold Corp. It specifies the record dates, meeting date, and proxy-related mailing instructions. This is a standard administrative notice sent prior to a shareholder meeting to set the logistics, which falls under the category of Proxy Solicitation & Information Statement materials.
2026-01-13 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing a 'private placement financing' for NetraMark Holdings Inc. It details the terms of the offering, including the number of units, price per unit, use of proceeds, and regulatory compliance. This falls directly under the definition of a Capital/Financing Update (CAP), as it describes fundraising activities and changes to the company's capital structure.
2026-01-13 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release issued by NetraMark Holdings Inc. on December 18, 2025. It provides a business update, highlighting operational milestones such as contract backlog growth, FDA engagement, scientific publications, and research collaborations. It also includes forward-looking financial guidance. This type of document is a standard corporate announcement of business progress and financial outlook, which falls under the 'Earnings Release' (ER) category in this taxonomy, as it serves as the primary vehicle for communicating periodic business performance and key highlights to the market. Q1 2026
2025-12-18 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by NetraMark Holdings Inc. announcing the completion of a Critical Path Innovation Meeting (CPIM) with the FDA. It details the scientific discussions held, the potential for future regulatory dialogue, and the implications for the company's AI platform. As it is a general corporate announcement regarding regulatory interactions and business milestones that does not fit into specific categories like financial reports, dividends, or board changes, it is classified as a Regulatory Filing (RNS).
2025-12-15 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by NetraMark Holdings Inc. announcing the acceptance of a peer-reviewed research paper for publication in a scientific journal (npj Digital Medicine). It describes the company's technology, the research findings, and includes standard corporate boilerplate and forward-looking statements. Since it does not fit into specific financial reporting categories like 10-K, ER, or IR, and is a general corporate announcement regarding business/scientific progress, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2025-12-08 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by NetraMark Holdings Inc. announcing the signing of four new contracts with a global pharmaceutical company. It describes the nature of the business engagement, the technology involved (NetraAI), and provides forward-looking statements. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding business operations and contract wins, it falls under the 'Regulatory Filings' (RNS) category as a catch-all for general corporate news releases.
2025-11-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.